Cargando…

WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS

Detalles Bibliográficos
Autores principales: Stepanova MD, N., Korol, L., Rysyev, A., Poperechnyi, I., Chernianu, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025651/
http://dx.doi.org/10.1016/j.ekir.2023.02.999
_version_ 1784909382730907648
author Stepanova MD, N.
Korol, L.
Rysyev, A.
Poperechnyi, I.
Chernianu, D.
author_facet Stepanova MD, N.
Korol, L.
Rysyev, A.
Poperechnyi, I.
Chernianu, D.
author_sort Stepanova MD, N.
collection PubMed
description
format Online
Article
Text
id pubmed-10025651
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100256512023-03-21 WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS Stepanova MD, N. Korol, L. Rysyev, A. Poperechnyi, I. Chernianu, D. Kidney Int Rep Covid-19 and CKD Published by Elsevier Inc. 2023-03 2023-03-20 /pmc/articles/PMC10025651/ http://dx.doi.org/10.1016/j.ekir.2023.02.999 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19 and CKD
Stepanova MD, N.
Korol, L.
Rysyev, A.
Poperechnyi, I.
Chernianu, D.
WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title_full WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title_fullStr WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title_full_unstemmed WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title_short WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
title_sort wcn23-0089 serum indoxyl sulfate is associated with covid-19 infection and disease severity in hemodialysis patients
topic Covid-19 and CKD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025651/
http://dx.doi.org/10.1016/j.ekir.2023.02.999
work_keys_str_mv AT stepanovamdn wcn230089serumindoxylsulfateisassociatedwithcovid19infectionanddiseaseseverityinhemodialysispatients
AT koroll wcn230089serumindoxylsulfateisassociatedwithcovid19infectionanddiseaseseverityinhemodialysispatients
AT rysyeva wcn230089serumindoxylsulfateisassociatedwithcovid19infectionanddiseaseseverityinhemodialysispatients
AT poperechnyii wcn230089serumindoxylsulfateisassociatedwithcovid19infectionanddiseaseseverityinhemodialysispatients
AT chernianud wcn230089serumindoxylsulfateisassociatedwithcovid19infectionanddiseaseseverityinhemodialysispatients